Gagne JJ - Search Results

1

Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected.

Raebel MA, Shetterly S, Lu CY, Flory J, Gagne JJ, Harrell FE, Haynes K, Herrinton LJ, Patorno E, Popovic J, Selvan M, Shoaibi A, Wang X, Roy J. Raebel MA, et al. Among authors: gagne jj. Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):798-814. doi: 10.1002/pds.4015. Epub 2016 May 4. Pharmacoepidemiol Drug Saf. 2016. PMID: 27146273

2

Aprotinin and the risk of death and renal dysfunction in patients undergoing cardiac surgery: a meta-analysis of epidemiologic studies.

Gagne JJ, Griesdale DE, Schneeweiss S. Gagne JJ, et al. Pharmacoepidemiol Drug Saf. 2009 Apr;18(4):259-68. doi: 10.1002/pds.1714. Pharmacoepidemiol Drug Saf. 2009. PMID: 19185048

3

Confounder summary scores when comparing the effects of multiple drug exposures.

Cadarette SM, Gagne JJ, Solomon DH, Katz JN, Stürmer T. Cadarette SM, et al. Among authors: gagne jj. Pharmacoepidemiol Drug Saf. 2010 Jan;19(1):2-9. doi: 10.1002/pds.1845. Pharmacoepidemiol Drug Saf. 2010. PMID: 19757416 Free PMC article.

4

An event-based approach for comparing the performance of methods for prospective medical product monitoring.

Gagne JJ, Walker AM, Glynn RJ, Rassen JA, Schneeweiss S. Gagne JJ, et al. Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):631-9. doi: 10.1002/pds.2347. Epub 2012 Jan 4. Pharmacoepidemiol Drug Saf. 2012. PMID: 22223544 Free PMC article.

5

Design considerations in an active medical product safety monitoring system.

Gagne JJ, Fireman B, Ryan PB, Maclure M, Gerhard T, Toh S, Rassen JA, Nelson JC, Schneeweiss S. Gagne JJ, et al. Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:32-40. doi: 10.1002/pds.2316. Pharmacoepidemiol Drug Saf. 2012. PMID: 22262591

6

Early steps in the development of a claims-based targeted healthcare safety monitoring system and application to three empirical examples.

Wahl PM, Gagne JJ, Wasser TE, Eisenberg DF, Rodgers JK, Daniel GW, Wilson M, Schneeweiss S, Rassen JA, Patrick AR, Avorn J, Bohn RL. Wahl PM, et al. Among authors: gagne jj. Drug Saf. 2012 May 1;35(5):407-16. doi: 10.2165/11594770-000000000-00000. Drug Saf. 2012. PMID: 22489640

7

Role of disease risk scores in comparative effectiveness research with emerging therapies.

Glynn RJ, Gagne JJ, Schneeweiss S. Glynn RJ, et al. Among authors: gagne jj. Pharmacoepidemiol Drug Saf. 2012 May;21 Suppl 2(Suppl 2):138-47. doi: 10.1002/pds.3231. Pharmacoepidemiol Drug Saf. 2012. PMID: 22552989 Free PMC article.

8

Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates.

Brunelli SM, Gagne JJ, Huybrechts KF, Wang SV, Patrick AR, Rothman KJ, Seeger JD. Brunelli SM, et al. Among authors: gagne jj. Pharmacoepidemiol Drug Saf. 2013 May;22(5):542-50. doi: 10.1002/pds.3434. Epub 2013 Mar 22. Pharmacoepidemiol Drug Saf. 2013. PMID: 23526818 Free PMC article.

9

Risk of death associated with the use of conventional vs. atypical antipsychotic medications: evaluating the use of the Emilia-Romagna Region database for pharmacoepidemiological studies.

Sikirica S, Marino M, Gagne JJ, De Palma R, Maio V. Sikirica S, et al. Among authors: gagne jj. J Clin Pharm Ther. 2014 Feb;39(1):38-44. doi: 10.1111/jcpt.12099. Epub 2013 Sep 16. J Clin Pharm Ther. 2014. PMID: 24102411

10

Near-real-time monitoring of new drugs: an application comparing prasugrel versus clopidogrel.

Gagne JJ, Rassen JA, Choudhry NK, Bohn RL, Patrick AR, Sridhar G, Daniel GW, Liu J, Schneeweiss S. Gagne JJ, et al. Drug Saf. 2014 Mar;37(3):151-61. doi: 10.1007/s40264-014-0136-0. Drug Saf. 2014. PMID: 24510605

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters